Fundlater

Company announcements

leave blank for all companies
leave blank for all announcements
announcements

~ We have limited the announcement data displayed on our website to the past 12 months to ensure its accuracy and usefulness.
Search Results
Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Proactive Investor Presentation May 2015 5 May 2015 2:07PM $0.115 $0.520 risen by 352.17%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 OncoSil Medical Investor Presentation announcement 5 May 2015 2:01PM $0.115 $0.520 risen by 352.17%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 OncoSil Medical - Director resignation 4 May 2015 9:26AM $0.105 $0.520 risen by 395.24%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Appendix 4C - quarterly 28 Apr 2015 8:26AM $0.087 $0.520 risen by 497.70%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 OncoSil Medical ISO Certification Announcement 27 Apr 2015 8:26AM $0.082 $0.520 risen by 534.15%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 OncoSil HCC Announcement 16 Mar 2015 9:20AM n/a $0.520 n/a
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Half Year Accounts 26 Feb 2015 4:36PM n/a $0.520 n/a
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Global Registration Plan advances 25 Feb 2015 9:34AM n/a $0.520 n/a
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Global Registration Plan advances 25 Feb 2015 9:34AM n/a $0.520 n/a
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Appendix 4C - quarterly 27 Jan 2015 5:06PM n/a $0.520 n/a
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 R&D Incentive Approval 16 Dec 2014 9:23AM $0.082 $0.520 risen by 534.15%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Appointment of CEO 11 Nov 2014 8:30AM $0.110 $0.520 risen by 372.73%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Appendix 4C - Quarterly 28 Oct 2014 9:15AM $0.105 $0.520 risen by 395.24%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Board and senior management restructure 9 Sep 2014 2:46PM $0.130 $0.520 risen by 300%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Appendix 4E 29 Aug 2014 9:22AM $0.105 $0.520 risen by 395.24%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Appendix 4C - quarterly 31 Jul 2014 11:29AM $0.130 $0.520 risen by 300%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 GMP manufacturing process finalised for OncoSil Medical 16 Jul 2014 9:23AM $0.105 $0.520 risen by 395.24%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Ethics Approval Granted for OncoSil in Pancreatic Cancer 15 Jul 2014 9:08AM $0.099 $0.520 risen by 425.25%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Appendix 4C - quarterly 22 Apr 2014 9:17AM $0.096 $0.520 risen by 441.67%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 OncoSil Medical commences Pivotal Trial 17 Mar 2014 8:43AM $0.130 $0.520 risen by 300%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Appendix 4D and Half Year Report 27 Feb 2014 4:17PM $0.130 $0.520 risen by 300%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Oncosil's next generation delivery platform 20 Feb 2014 8:42AM $0.125 $0.520 risen by 316%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Appendix 4C - quarterly 29 Jan 2014 9:41AM $0.140 $0.520 risen by 271.43%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Appendix 4C - quarterly 25 Oct 2013 8:55AM $0.140 $0.520 risen by 271.43%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 US patent for OncoSil granted by the US PTO 18 Oct 2013 9:50AM $0.150 $0.520 risen by 246.67%

726 - 750 of 759 results

Page 30 of 31

  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.